Amneal Pharmaceuticals rises on annual revenue forecast raise
** Shares of Amneal Pharmaceuticals AMRX.O rise 2.6% to
$7.98
** Co raises annual revenue forecast to $2.70 bln to $2.80
bln from prior view of $2.55 bln to $2.65 bln
** Also lifts lower end of FY adj. profit forecast range to
57 cents - 63 cents per share from 53 cents - 63 cents
previously
** AMRX posts Q2 net revenue of $702 mln, 17% higher than
$599 mln a year ago
** Including session's moves, stock up 27.2% YTD
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com;))
Recent news on Amneal Pharmaceuticals
See all newsFocus: US progesterone supplies tighten as menopause treatment demand grows
U.S. STOCKS ON THE MOVE-Chipotle Mexican Grill, J.B. Hunt, ABM Industries
U.S. STOCKS ON THE MOVE-G-III Apparel, Amneal Pharmaceuticals, BioCardia
U.S. STOCKS ON THE MOVE-Lululemon, Cooper Companies, Cypherpunk Technologies
Amneal Pharma up after Parkinson’s drug shows benefit in late-stage study